Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
72 results
  • Lung Cancer

19-368          Phase II

A Biomarker-Directed Phase 2 Platform Study in Patients with Advanced Non-Small Cell Lung Cancer whose Disease has Progressed on First-Line Osimertinib Therapy (ORCHARD) (View details on

  • Lung Cancer

20-372          Phase II

A Double-blind, Placebo Controlled, Randomized, Phase II Study Evaluating the Efficacy and Safety of Capmatinib (INC280) and Spartalizumab (PDR001) Combination Therapy Versus Capmatinib and Placebo as First Line Treatment for Locally Advanced or Metastatic Non-Small Cell Lung Cancer Patients with MET Exon 14 Skipping Mutations (View details on

  • Breast Cancer, Melanoma, Lung Cancer, Ovarian Cancer, Colorectal Cancer

20-079          Phase I

A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies (View details on

  • Lung Cancer, Colorectal Cancer

20-177          Phase I

A First-in-Human, Phase 1a/1b, Open-Label, Dose-Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, and Antitumor Activity of the RAF Dimer Inhibitor BGB-3245 in Patients with Advanced or Refractory Tumors (View details on

  • Bladder Cancer, Melanoma, Head and Neck Cancer, Lung Cancer

18-418          Phase III

A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial. (View details on

  • Lung Cancer

17-494          Phase I

A Multicenter, Open-Label Phase 1 Study of U3-1402 in Subjects with Metastatic or Unresectable EGFR-Mutant Non-Small Cell Lung Cancer (View details on

  • Lung Cancer, Colorectal Cancer, Melanoma

17-607          Phase I

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (View details on

  • Endometrial Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer

16-393          Phase I

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors (View details on

  • Metastatic/Advanced Cancer, Bladder Cancer, Cellular Therapy, Lung Cancer

17-553          Phase I

A Phase 1 Study Evaluating the Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Subjects with Advanced Cancers (View details on

  • Brain Tumors, Lung Cancer, Thyroid Cancer, Melanoma

20-200          Phase I

A Phase 1 Study of ERK1/2 Inhibitor JSI-1187 Administered as Monotherapy and in Combination with Dabrafenib for the Treatment of Advanced Solid Tumors with MAPK Pathway Mutations (View details on

Showing 1 - 10 of 72 results